Quarterly report pursuant to Section 13 or 15(d)

CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

v3.23.3
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
9 Months Ended
Sep. 30, 2023
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS  
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

4. CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

The Company’s cash equivalents and short-term investments are invested in the following (in thousands):

    

September 30, 2023

    

Amortized Cost

    

Unrealized Gains

    

Unrealized Losses

    

Fair Value

Money market funds

$

63,671

$

$

$

63,671

Total cash equivalents

63,671

63,671

Total short-term investments

Total cash equivalents and short-term investments

$

63,671

$

$

$

63,671

    

December 31, 2022

    

Amortized Cost

    

Unrealized Gains

    

Unrealized Losses

    

Fair Value

Money market funds

$

51,274

$

$

$

51,274

Total cash equivalents

51,274

51,274

Commercial paper

39,781

39,781

Corporate bonds

28,970

(156)

28,814

U.S. Treasury securities

19,896

(78)

19,818

Government bonds

14,846

(102)

14,744

Asset-backed securities

4,000

(2)

3,998

Total short-term investments

107,493

(338)

107,155

Total cash equivalents and short-term investments

$

158,767

$

$

(338)

$

158,429

During the year ended December 31, 2021, the Company made a $20.0 million investment in equity securities of a publicly-traded company. The Company records this investment at fair value within short-term investments, which was $0.8 million as of September 30, 2023. During the three and nine months ended September 30, 2023, the Company recorded unrealized losses of $0.1 million and $0.3 million, respectively, due to the change in fair value of the equity securities. During the three and nine months ended September 30, 2022, the Company recorded unrealized losses due to the change in fair value of the equity securities of $0.3 million and $6.2 million, respectively, in interest and other (expense) income, net in the consolidated statements of operations.